Zehan Chen

1.7k citations

30 papers · 1.3k indexed · h-index 17

Co-authors: Saul H. Rosenberg Thomas J. Sowin Haiying Zhang Zhan Xiao Angelo Gunasekera Peter Kovar Hing L. Sham Nan‐Horng Lin
Topics: Cancer-related Molecular Pathways (15 papers)DNA Repair Mechanisms (14 papers)Cancer therapeutics and mechanisms (9 papers)
Cited by: Oncology Molecular Biology Cell Biology
Journals: Nature Journal of Biological Chemistry Journal of Medicinal Chemistry
Partner nations: United States China United Kingdom

In The Last Decade

Zehan Chen

27 papers receiving 1.3k citations

Peers

Countries citing papers authored by Zehan Chen

Since Specialization

Citations

This map shows the geographic impact of Zehan Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zehan Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zehan Chen more than expected).

Fields of papers citing papers by Zehan Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zehan Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zehan Chen. The network helps show where Zehan Chen may publish in the future.

Co-authorship network of co-authors of Zehan Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Zehan Chen. A scholar is included among the top collaborators of Zehan Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zehan Chen. Zehan Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Research Status and Development Trend of Lower-Limb Squat-Assistant Wearable Devices 2025 ·Biomimetics ·(unknown),Zehan Chen,Robert Hong,Yilin Qu,(unknown),Xupeng Wang	1
2	VMD: A Visualizable Malware Detection Scheme Based on Multi-dimensional Dynamic Behavior Information 2024 ·(unknown),Zhiwei Zhang,Zhidong Ma,Zehan Chen,(unknown),Yulong Shen	0
3	MAKD:MULTIPLE Auxiliary Knowledge Distillation 2022 ·ICASSP 2022 - 2022 IEEE International Conference on Acoustics, Speech and Signal Processing (ICASSP) ·Zehan Chen,(unknown),Yuan He,Hui Xue	0
4	ABC-NET: Avoiding Blocking Effect & Color Shift Network for Single Image Dehazing Via Restraining Transmission Bias 2020 ·Cong Wang,Yuexian Zou,Zehan Chen	8
5	1-Benzyl-3-cetyl-2-methylimidazolium iodide (NH125) Induces Phosphorylation of Eukaryotic Elongation Factor-2 (eEF2) 2011 ·Journal of Biological Chemistry ·Zehan Chen,Sujatha M. Gopalakrishnan,(unknown),Niru B. Soni,Usha Warrior,Eric F. Johnson,(unknown),Keith B. Glaser	94
6	Investigation of novel 7,8-disubstituted-5,10-dihydro-dibenzo[b,e][1,4]diazepin-11-ones as potent Chk1 inhibitors 2008 ·Bioorganic & Medicinal Chemistry Letters ·Lisa Hasvold,Le Wang,(unknown),Zhan Xiao,Zehan Chen,Wen‐Zhen Gu,Philip J. Merta,John Xue,Peter Kovar,Haiying Zhang,Chang Park,Thomas J. Sowin,Saul H. Rosenberg,Nan‐Horng Lin	10
7	Cyanopyridyl containing 1,4-dihydroindeno[1,2-c]pyrazoles as potent checkpoint kinase 1 inhibitors: Improving oral biovailability 2007 ·Bioorganic & Medicinal Chemistry Letters ·Yunsong Tong,(unknown),Zhi‐Fu Tao,Jennifer J. Bouska,Kent D. Stewart,Chang Park,Gaoquan Li,Akiyo Claiborne,Peter Kovar,Zehan Chen,Philip J. Merta,(unknown),Amanda M. Olson,Donald J. Osterling,Haiying Zhang,Hing L. Sham,Saul H. Rosenberg,Thomas J. Sowin,Nan‐Horng Lin	5
8	Macrocyclic ureas as potent and selective Chk1 inhibitors: An improved synthesis, kinome profiling, structure–activity relationships, and preliminary pharmacokinetics 2007 ·Bioorganic & Medicinal Chemistry Letters ·Zhi‐Fu Tao,Zehan Chen,(unknown),Peter Kovar,Eric F. Johnson,Jennifer J. Bouska,Haiying Zhang,Saul H. Rosenberg,Thomas J. Sowin,Nan‐Horng Lin	13
9	Synthesis and in-vitro biological activity of macrocyclic urea Chk1 inhibitors 2007 ·Bioorganic & Medicinal Chemistry Letters ·Gaoquan Li,Zhi‐Fu Tao,Yunsong Tong,(unknown),Peter Kovar,Philip J. Merta,Zehan Chen,Haiying Zhang,Thomas J. Sowin,Saul H. Rosenberg,Nan‐Horng Lin	9
10	Synthesis and biological evaluation of 4′-(6,7-disubstituted-2,4-dihydro-indeno[1,2-c]pyrazol-3-yl)-biphenyl-4-ol as potent Chk1 inhibitors 2007 ·Bioorganic & Medicinal Chemistry Letters ·Zhi‐Fu Tao,Gaoquan Li,Yunsong Tong,Zehan Chen,Philip J. Merta,Peter Kovar,Haiying Zhang,Saul H. Rosenberg,Hing L. Sham,Thomas J. Sowin,Nan‐Horng Lin	22
11	Discovery of 1,4-dihydroindeno[1,2-c]pyrazoles as a novel class of potent and selective checkpoint kinase 1 inhibitors 2007 ·Bioorganic & Medicinal Chemistry ·Yunsong Tong,Akiyo Claiborne,Kent D. Stewart,Chang Park,Peter Kovar,Zehan Chen,R.B. Credo,Wen‐Zhen Gu,Stephen L. Gwaltney,Russell A. Judge,Haiying Zhang,Saul H. Rosenberg,Hing L. Sham,Thomas J. Sowin,Nan‐Horng Lin	33
12	Synthesis and biological evaluation of 1-(2,4,5-trisubstituted phenyl)-3-(5-cyanopyrazin-2-yl)ureas as potent Chk1 kinase inhibitors 2006 ·Bioorganic & Medicinal Chemistry Letters ·Gaoquan Li,Lisa Hasvold,Zhi‐Fu Tao,Gary T. Wang,Stephen L. Gwaltney,(unknown),Peter Kovar,R.B. Credo,Zehan Chen,Haiying Zhang,Chang Park,Hing L. Sham,Thomas J. Sowin,Saul H. Rosenberg,Nan‐Horng Lin	29
13	Selective Chk1 inhibitors differentially sensitize p53‐deficient cancer cells to cancer therapeutics 2006 ·International Journal of Cancer ·Zehan Chen,Zhan Xiao,Wen‐Zhen Gu,John Xue,Mai H. Bui,Peter Kovar,Gaoquan Li,Gary Wang,Zhi‐Fu Tao,Yunsong Tong,Nan‐Horng Lin,Hing L. Sham,Jean Y. J. Wang,Thomas J. Sowin,Saul H. Rosenberg,Haiying Zhang	103
14	Kinase Drug Discovery by Affinity Selection/Mass Spectrometry (ASMS): Application to DNA Damage Checkpoint Kinase Chk1 2006 ·SLAS DISCOVERY ·Kenneth M. Comess,(unknown),Chang Park,Zehan Chen,Russell A. Judge,Martin J. Voorbach,Michael Coen,Lan Gao,Hua Tang,Peter Kovar,Xueheng Cheng,Mark E. Schurdak,Haiying Zhang,(unknown),David J. Burns	24
15	Synthesis and biological evaluation of 3-ethylidene-1,3-dihydro-indol-2-ones as novel checkpoint 1 inhibitors 2005 ·Bioorganic & Medicinal Chemistry Letters ·Nan‐Horng Lin,(unknown),Peter Kovar,Chang Park,Zehan Chen,Haiying Zhang,Saul H. Rosenberg,Hing L. Sham	35
16	1-(5-Chloro-2-alkoxyphenyl)-3-(5-cyano- pyrazi-2-yl)ureas as Potent and Selective Inhibitors of Chk1 Kinase: Synthesis, Preliminary SAR, and Biological Activities 2005 ·Journal of Medicinal Chemistry ·Gary T. Wang,Gaoquan Li,Robert A. Mantei,Zehan Chen,Peter Kovar,(unknown),Zhan Xiao,Haiying Zhang,Hing L. Sham,Thomas J. Sowin,Saul H. Rosenberg,Nan‐Horng Lin	35
17	Chk1 Mediates S and G2 Arrests through Cdc25A Degradation in Response to DNA-damaging Agents 2003 ·Journal of Biological Chemistry ·Zhan Xiao,Zehan Chen,Angelo Gunasekera,Thomas J. Sowin,Saul H. Rosenberg,(unknown),Haiying Zhang	286
18	Downregulation of Akt1 Inhibits Anchorage-Independent Cell Growth and Induces Apoptosis in Cancer Cells 2001 ·Neoplasia ·Xuesong Liu,Yan Shi,Edward K. Han,Zehan Chen,Saul H. Rosenberg,Vincent L. Giranda,Yan Luo,Shi‐Chung Ng	40
19	Blocking CHK1 Expression Induces Apoptosis and Abrogates the G2 Checkpoint Mechanism 2001 ·Neoplasia ·Yan Luo,(unknown),Paul E. Kroeger,Leigh Frost,Zehan Chen,Edward K. Han,Shi‐Chung Ng,Robert L. Simmer,Vincent L. Giranda	39
20	NMR structure and mutagenesis of the FADD (Mort1) death-effector domain 1998 ·Nature ·Matthias Eberstadt,Baohua Huang,Zehan Chen,Robert Meadows,(unknown),Lixin Zheng,Michael J. Lenardo,Stephen W. Fesik	212

About Zehan Chen

Zehan Chen is a scholar working on Oncology, Aging and Cell Biology, having authored 30 papers that have together received 1.3k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (15 papers), DNA Repair Mechanisms (14 papers) and Cancer therapeutics and mechanisms (9 papers). The work is most often cited by research in Oncology (448 citations), Molecular Biology (1.0k citations) and Cell Biology (188 citations). Zehan Chen has collaborated with scholars based in United States, China and United Kingdom. Frequent co-authors include Saul H. Rosenberg, Thomas J. Sowin, Haiying Zhang, Zhan Xiao, Angelo Gunasekera, Peter Kovar, Hing L. Sham, Nan‐Horng Lin, Robert Meadows and Baohua Huang. Their work appears in journals such as Nature, Journal of Biological Chemistry and Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact